DAA treatment failures in a low-resource setting with a high burden of hepatitis C infections: a case series

Globally, 58 million people are living with hepatitis C virus (HCV) infection and 1.5 million new patients are infected every year. The advent of direct acting antivirals (DAAs) has revolutionized the treatment of HCV, opening the door to the ambitious World Health Organization HCV infection elimina...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahid, Hassaan, Aslam, Khawar, Dahl, Elin Hoffmann, Abbassi, Waqas, Adan, Suleiman, Van den Bergh, Rafael, Balinska, Marta A, Luck, Nasir Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127947/
https://www.ncbi.nlm.nih.gov/pubmed/35619685
http://dx.doi.org/10.1093/omcr/omac049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127947/
https://www.ncbi.nlm.nih.gov/pubmed/35619685
http://dx.doi.org/10.1093/omcr/omac049

Ejemplares similares